A61P 31/08
For leprosy
Official title: for leprosy
A61P31/08 (For leprosy) appears on 584 US grants and 928 published applications in this corpus.
Search patents in A61P- Granted patents
- 584
- Published applications
- 928
- Assignees
- 324
- Inventors
- 1,446
- Latest grant
- 24 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 2 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 4 | 0 |
| 2000 | 1 | 0 |
| 2001 | 11 | 1 |
| 2002 | 12 | 17 |
| 2003 | 14 | 32 |
| 2004 | 13 | 46 |
| 2005 | 17 | 51 |
| 2006 | 11 | 48 |
| 2007 | 18 | 39 |
| 2008 | 16 | 32 |
| 2009 | 22 | 57 |
| 2010 | 49 | 133 |
| 2011 | 40 | 83 |
| 2012 | 55 | 57 |
| 2013 | 56 | 52 |
| 2014 | 54 | 61 |
| 2015 | 31 | 37 |
| 2016 | 32 | 38 |
| 2017 | 26 | 34 |
| 2018 | 25 | 25 |
| 2019 | 23 | 19 |
| 2020 | 14 | 16 |
| 2021 | 16 | 18 |
| 2022 | 7 | 7 |
| 2023 | 1 | 10 |
| 2024 | 7 | 8 |
| 2025 | 4 | 4 |
| 2026 | 1 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Indazole based compounds and associated methods of use24 Feb 2026US 12,559,506 B2Arvinas Operations, Inc.
- Compounds and methods of use thereof as antibacterial agents4 Nov 2025US 12,459,933 B2Merck Sharp & Dohme Corp.
- Method for inhibiting bone resorption23 Sep 2025US 12,421,304 B2Amgen Inc.
- Purified double negative T cell and preparation and use thereof26 Aug 2025US 12,398,369 B2Beijing Immutech LLC
- Highly active sting protein agonist compound22 Jul 2025US 12,364,702 B2Adlai Nortye Biopharma Co., Ltd.
- Inhibitors of lrrk213 Aug 2026US 2026/0232636 A1Vanderbilt University
- Compounds and methods of use thereof as antibacterial agents5 Feb 2026US 2026/0035363 A1Merck Sharp & Dohme Corp.
- Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof29 Jan 2026US 2026/0027110 A1Insmed Incorporated
- Isoindolinone derivative having glutarimide mother nucleus, and use thereof13 Nov 2025US 2025/0346575 A1Korea Research Institute of Chemical Technology
- Methods of treating mycobacterial infections using tetracycline compounds30 Oct 2025US 2025/0332178 A1Paratek Pharmaceuticals, Inc.
Most cited
By later US patents
- Immune response modifier compounds for treatment of TH2 mediated and related diseases285US 6,039,969 A3M Innovative Properties Company · 2000
- Site specific delivery of nucleic acids by combining targeting ligands with endosomolytic components256US 9,345,780 B2Tekmira Pharmaceuticals Corporation · 2016
- Imidazonaphthyridines255US 6,194,425 B13M Innovative Properties Company · 2001
- Amide substituted imidazoquinolines237US 6,451,810 B13M Innovative Properties Company · 2002
- Thioether substituted imidazoquinolines177US 6,664,264 B23M Innovative Properties Company · 2003